Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages

Blood

Volumn 111, Issue 12, 2008, Pages 5562-5570

  Karsunky, Holger ^a,b   Inlay, Matthew A ^a   Serwold, Thomas ^a   Bhattacharya, Deepta ^a   Weissman, Irving L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cellerant Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN FLK 2; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; CD135 ANTIGEN; FLT3 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMUS; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL MOUSE; CONGENIC STRAIN; CYTOLOGY; DENDRITIC CELL; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MOUSE MUTANT; NATURAL KILLER CELL;

ANIMALS; ANIMALS, CONGENIC; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; DENDRITIC CELLS; FMS-LIKE TYROSINE KINASE 3; HEMATOPOIETIC STEM CELLS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MYELOID CELLS; T-LYMPHOCYTES;

EID: 47049088149     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-11-126219     Document Type: Article

References (27)

1. Kondo M, Wagers AJ, Manz MG, et al. Biology of hematopoietic stem cells and progenitors: implications tor clinical application. Annu Rev Immunol. 2003;21:759-806.
2. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000:404:193-197.
3. Traver D, Akashi K, Manz M, et al. Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science. 2000;290:2152-2154.
4. Mende I, Karsunky H, Weissman IL. Engleman EG, Merad M. Flk2+ myeloid progenitors are the main source of Langerhans cells. Blood. 2006; 107:1383-1390.
5. Karsunky H, Merad M, Mende I, Manz MG, Engleman EG, Weissman IL. Developmental origin of interferon-alpha-producing dendritic cells from hematopoietic precursors. Exp Hematol. 2005;33:173-181.
6. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997;91:661-672.
7. Allman D, Sambandam A, Kim S, et al. Thymo-poiesis independent of common lymphoid progenitors. Nat Immunol. 2003;4:168-174.
8. Harman BC, Miller JP, Nikbakht N, Gerstein R, Allman D. Mouse plasmacytoid dendritic cells derive exclusively from estrogen-resistant myeloid progenitors. Blood. 2006;108:878-885.
9. Schwarz BA, Bhandoola A. Circulating hematopoietic progenitors with T lineage potential. Nat Immunol. 2004;5:953-960.
10. Balciunaite G, Ceredig R, Massa S, Rolink AG. A B220+ CD117+ CD19- hematopoietic progenitor with potent lymphoid and myeloid developmental potential. Eur J Immunol. 2005;35:2019-2030.
11. Perry SS, Welner RS, Kouro T, Kincade PW, Sun XH. Primitive lymphoid progenitors in bone marrow with T lineage reconstituting potential. J Immunol. 2006;177:2880-2887.
12. Rumfelt LL. Zhou Y, Rowley BM, Shinton SA, Hardy RR. Lineage specification and plasticity in CD19- early B cell precursors. J Exp Med. 2006;203:675-687.
13. Ye M. Graf T. Early decisions in lymphoid development. Curr Opin Immunol. 2007;19:123-128.
14. Pelayo R, Welner R, Perry SS, et al. Lymphoid progenitors and primary routes to becoming cells of the immune system. Curr Opin Immunol. 2005;17:100-107.
15. Bhandoola A, von Boehmer H, Petrie HT, Zuniga-Pflucker JC. Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity. 2007;26:678-689.
16. Lyman SD, Jacobsen SE. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood. 1998;91:1101-1134.
17. Karsunky H, Merad M, Cozzio A, Weissman IL, Manz MG. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J Exp Med. 2003;198:305-313.
18. Adolfsson J, Borge OJ, Bryder D, et al. Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1 (+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity. 2001;15:659-669.
19. Christensen JL, Weissman IL. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci U S A. 2001;98:14541-14546.
20. Forsberg EC, Serwold T, Kogan S, Weissman IL, Passegue E. New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+multipotent hematopoietic progenitors. Cell. 2006;126:415-426.
21. Jerabek L, Weissman IL. Intrathymic injection for analysis of T-cell progenitor activity. In Klug CA, Jordan CT. Hematopoietic stem cell protocols. Totowa, NJ: Humana Press, 2002;161-165.
22. Izon D, Rudd K, DeMuth W, et al. A common pathway for dendritic cell and early B cell development. J Immunol. 2001;167:1387-1392.
23. Borghesi L, Hsu LY, Miller JP, et al. B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors. J Exp Med. 2004;199:491-502.
24. Borghesi L, Aites J, Nelson S, Lefterov P, James P, Gerstein R. E47 is required for V(D)J recombinase activity in common lymphoid progenitors. J Exp Med. 2005;202:1669-1677.
25. Miller JP, Izon D, DeMuth W, Gerstein R, Bhandoola A, Allman D. The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7. J Exp Med. 2002:196:705-711.
26. Schmitt TM, Zuniga-Pflucker JC. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity. 2002;17:749-756.
27. Huntington ND, Vosshenrich CA, Di Santo JP. Developmental pathways that generate natural- killer-cell diversity in mice and humans. Nat Rev Immunol. 2007:7:703-714.